KIORA PHARMACEUTICALS, INC. Other Nonoperating Expense
KIORA PHARMACEUTICALS, INC. (KPRX) reported Other Nonoperating Expense of $937 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2022-11-09
- KIORA PHARMACEUTICALS, INC. other nonoperating expense for the quarter ending 2022-09-30 was $937.00.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 9 month |
|---|---|---|
| 2022-09-30 | $937.00 10-Q · filed 2022-11-09 | $5.15K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |